NR2F2-AS1 is upregulated in several malignancies, such as non-small cell lung cancer, clear cell renal cell carcinoma, and prostate, cervical, nasopharynx, and esophageal cancers, being considered an oncogene [101], contrary to what we observed in EOC. This evidence concerns the gene NR2F2 and esophageal cancer.